timing

Imagine a pharmaceutical company spends nearly four years touting a ground-breaking new medicine that will cure all diseases.Early evidence supporting those claims is limited, and massive questions remain, but the company continues to make progress. Criticism and concerns, while addressed, don’t slow its aggressive push.After all, investors believe this is…